nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Molecular Signature Response Classifier to Predict Inadequate Response to Tumor Necrosis Factor-α Inhibitors: The NETWORK-004 Prospective Observational Study
|
Cohen, Stanley |
|
|
|
3 |
p. 1159-1176 |
artikel |
2 |
Analysis of the Pharmacoutilization of Biological Drugs in Psoriatic Arthritis Patients: A Real-World Retrospective Study Among an Italian Population
|
Perrone, Valentina |
|
|
|
3 |
p. 875-890 |
artikel |
3 |
A Narrative Literature Review Comparing the Key Features of Musculoskeletal Involvement in Rheumatoid Arthritis and Systemic Lupus Erythematosus
|
Dörner, Thomas |
|
|
|
3 |
p. 781-802 |
artikel |
4 |
A Narrative Review of Acthar Gel for the Treatment of Myositis
|
Chandra, Tanya |
|
|
|
3 |
p. 523-537 |
artikel |
5 |
An Innovative Online Qualitative Study to Explore the Symptom Experience of Patients with Primary Sjögren’s Syndrome
|
Gairy, Kerry |
|
|
|
3 |
p. 601-615 |
artikel |
6 |
An Observational Retrospective Matched Cohort Study of Healthcare Resource Utilisation and Costs in UK Patients with Moderate to Severe Osteoarthritis Pain
|
Abraham, Lucy |
|
|
|
3 |
p. 851-874 |
artikel |
7 |
A Real-World Claims Database Study Assessing Long-Term Persistence with Golimumab Treatment in Patients with Rheumatoid Arthritis in Japan
|
Miyashiro, Masahiko |
|
|
|
3 |
p. 615-634 |
artikel |
8 |
A Threshold of Meaning for Work Disability Improvement in Psoriatic Arthritis Measured by the Work Productivity and Activity Impairment Questionnaire
|
Tillett, William |
|
2019 |
|
3 |
p. 379-391 |
artikel |
9 |
Awareness and Expectations Surrounding Family Planning and Pregnancy Among Danish Patients with Chronic Inflammatory Disease of the Skin or Joints: Results from an Online Survey
|
Johansen, Cæcilie B. |
|
|
|
3 |
p. 1419-1433 |
artikel |
10 |
Baricitinib and the Risk of Incident Interstitial Lung Disease: A Descriptive Clinical Case Report from Clinical Trials
|
Salvarani, Carlo |
|
|
|
3 |
p. 1435-1441 |
artikel |
11 |
Biologic Disease-Modifying Antirheumatic Drug Prescription Patterns Among Rheumatologists in Europe and Japan
|
Sullivan, Emma |
|
|
|
3 |
p. 517-535 |
artikel |
12 |
Clinical and Economic Burden of Systemic Lupus Erythematosus in the Years Preceding End-Stage Kidney Disease Diagnosis: A Retrospective Observational Study
|
Huang, Shirley P. |
|
|
|
3 |
p. 551-562 |
artikel |
13 |
Clinical Characteristics of Dermatomyositis with Interstitial Lung Disease: A Retrospective Case–Control Study
|
Weng, Chenghua |
|
|
|
3 |
p. 635-648 |
artikel |
14 |
Clinical Efficacy of Sarilumab Versus Upadacitinib Over 12 weeks: An Indirect Treatment Comparison
|
Huizinga, Thomas |
|
|
|
3 |
p. 539-550 |
artikel |
15 |
Clinical Presentation and Treatment of Juvenile Idiopathic Arthritis Combined with Lung Disease: A Narrative Review
|
Gao, Feng-Qiao |
|
|
|
3 |
p. 507-522 |
artikel |
16 |
Comparative Effectiveness of Abatacept vs. Tofacitinib in Rheumatoid Arthritis Patients who are CCP+
|
Harrold, Leslie R. |
|
|
|
3 |
p. 575-587 |
artikel |
17 |
Cost-Effectiveness of Therapeutic Drug Monitoring-Guided Adalimumab Therapy in Rheumatic Diseases: A Prospective, Pragmatic Trial
|
Gómez-Arango, Catalina |
|
|
|
3 |
p. 1323-1339 |
artikel |
18 |
Disease Activity and Patient-Reported Health Measures in Relation to Cytokine Levels in Ankylosing Spondylitis
|
Nossent, Johannes C. |
|
2019 |
|
3 |
p. 369-378 |
artikel |
19 |
Disease Characteristics and the Burden of Joint and Skin Involvement Amongst People With Psoriatic Arthritis: A Population Survey
|
Tillett, William |
|
|
|
3 |
p. 617-637 |
artikel |
20 |
Effect of Secukinumab on Traditional Cardiovascular Risk Factors and Inflammatory Biomarkers: Post Hoc Analyses of Pooled Data Across Three Indications
|
Merola, Joseph F. |
|
|
|
3 |
p. 935-955 |
artikel |
21 |
Effect of Upadacitinib on Disease Activity, Pain, Fatigue, Function, Health-Related Quality of Life and Work Productivity for Biologic Refractory Ankylosing Spondylitis
|
Navarro-Compán, Victoria |
|
|
|
3 |
p. 679-691 |
artikel |
22 |
Efficacy and Safety of CMAB008 Compared with Innovator Infliximab in Patients with Moderate-to-Severe Rheumatoid Arthritis Receiving Concomitant Methotrexate: A Randomized, Double-blind, Multi-center, Phase III Non-inferiority Study
|
Ye, Hua |
|
|
|
3 |
p. 757-773 |
artikel |
23 |
Efficacy and Safety of Subcutaneous Secukinumab 150 mg with or Without Loading Regimen in Psoriatic Arthritis: Results from the FUTURE 4 Study
|
Kivitz, Alan J. |
|
2019 |
|
3 |
p. 393-407 |
artikel |
24 |
Enhancement of an Auto-Injector Device for Self-Administration of Etanercept in Patients With Rheumatoid Arthritis Confers Emotional and Functional Benefits
|
Rekaya, Naceur |
|
|
|
3 |
p. 537-552 |
artikel |
25 |
Evaluation of Real-World Healthcare Resource Utilization and Associated Costs in Children with Juvenile Idiopathic Arthritis: A Canadian Retrospective Cohort Study
|
Grazziotin, Luiza R. |
|
|
|
3 |
p. 1303-1322 |
artikel |
26 |
Factors Associated with Health-Related Quality of Life in Psoriatic Arthritis Patients: A Longitudinal Analysis
|
Freites Nuñez, Dalifer |
|
|
|
3 |
p. 1341-1354 |
artikel |
27 |
Features and Outcomes of Microcrystalline Arthritis Treated by Biologics: A Retrospective Study
|
Doaré, Elise |
|
|
|
3 |
p. 1241-1253 |
artikel |
28 |
Hospitalization Among Pulmonary Arterial Hypertension Patients With and Without Connective Tissue Disease Comorbidities Prescribed Oral Selexipag
|
Tsang, Yuen |
|
|
|
3 |
p. 741-756 |
artikel |
29 |
Immune Thrombocytopenia Could be an Independent Clinical Phenotype of Antiphospholipid Syndrome: A Prospective Cohort Study
|
Shi, Yu |
|
|
|
3 |
p. 649-658 |
artikel |
30 |
Immunogenicity of Sarilumab Monotherapy in Patients with Rheumatoid Arthritis Who Were Inadequate Responders or Intolerant to Disease-Modifying Antirheumatic Drugs
|
Wells, Alvin F. |
|
2019 |
|
3 |
p. 339-352 |
artikel |
31 |
Increased Efficacy and Tolerability of Pegloticase in Patients With Uncontrolled Gout Co-Treated With Methotrexate: A Retrospective Study
|
Albert, John A. |
|
|
|
3 |
p. 639-648 |
artikel |
32 |
Induction of Sustained Clinical Remission in Early Axial Spondyloarthritis Following Certolizumab Pegol Treatment: 48-Week Outcomes from C-OPTIMISE
|
Landewé, Robert |
|
|
|
3 |
p. 581-599 |
artikel |
33 |
Insight into the Quality of Life of Patients with Ankylosing Spondylitis: Real-World Data from a US-Based Life Impact Survey
|
Rosenbaum, James T. |
|
2019 |
|
3 |
p. 353-367 |
artikel |
34 |
Long-Term Durability of Certolizumab Pegol in Patients with Rheumatoid Arthritis Over 5 Years: An Analysis of Pooled Clinical Trial Data
|
Bykerk, Vivian P. |
|
|
|
3 |
p. 693-706 |
artikel |
35 |
Malignancy Risk of Immunoglobin G4-Related Disease: Evidence from a Large Cohort Multicenter Retrospective Study
|
Liu, Yanying |
|
|
|
3 |
p. 1207-1221 |
artikel |
36 |
Mycophenolic Acid Exposure Optimization Based on Vitamin D Status in Children with Systemic Lupus Erythematosus: A Single-Center Retrospective Study
|
Ye, Qiaofeng |
|
|
|
3 |
p. 1143-1157 |
artikel |
37 |
Novel Interventional Techniques for Chronic Pain with Minimally Invasive Arthrodesis of the Sacroiliac Joint: (INSITE, iFuse, Tricor, Rialto, and others)
|
Kaye, Alan D. |
|
|
|
3 |
p. 1061-1072 |
artikel |
38 |
Nurse-Led Care for Stable Patients with Rheumatoid Arthritis: Quality of Care in Routine Practice Compared to the Traditional Rheumatologist-Led Model
|
Lopatina, Elena |
|
|
|
3 |
p. 1263-1285 |
artikel |
39 |
Obesity and Psoriatic Arthritis: A Narrative Review
|
Kumthekar, Anand |
|
|
|
3 |
p. 447-456 |
artikel |
40 |
Osteonecrosis in Primary Antiphospholipid Syndrome is Associated with Previous Glucocorticoid Use and Thrombocytopenia
|
Freire de Carvalho, Jozélio |
|
|
|
3 |
p. 1255-1261 |
artikel |
41 |
Pain Medication and Corticosteroid Use in Ankylosing Spondylitis, Psoriatic Arthritis, and Rheumatoid Arthritis in the United States: A Retrospective Observational Study
|
Hunter, Theresa |
|
|
|
3 |
p. 1371-1382 |
artikel |
42 |
Pain Pharmacotherapy in a Large Cohort of Patients with Osteoarthritis: A Real-World Data Analysis
|
Fallach, Noga |
|
|
|
3 |
p. 1129-1141 |
artikel |
43 |
Patient Experience of Sjögren’s Disease and its Multifaceted Impact on Patients’ Lives
|
Perella, Chiara |
|
|
|
3 |
p. 601-614 |
artikel |
44 |
Patient Experiences, Satisfaction, and Expectations with Current Systemic Lupus Erythematosus Treatment: Results of the SLE-UPDATE Survey
|
Birt, Julie A. |
|
|
|
3 |
p. 1189-1205 |
artikel |
45 |
Patient Perception of Medical Care for Psoriatic Arthritis in North America and Europe: Results from a Global Patient Survey
|
Richette, Pascal |
|
|
|
3 |
p. 823-838 |
artikel |
46 |
Patient Perceptions of Unmet Medical Need in Rheumatoid Arthritis: A Cross-Sectional Survey in the USA
|
Radawski, Christine |
|
2019 |
|
3 |
p. 461-471 |
artikel |
47 |
Patient Preference for Treatment Mode of Biologics in Rheumatoid Arthritis: A 2020 Web-based Survey in Japan
|
Kishimoto, Mitsumasa |
|
|
|
3 |
p. 1095-1111 |
artikel |
48 |
Patient-Reported Outcome Measures in Takayasu Arteritis: A Systematic Review and Meta-Analysis
|
Misra, Durga P. |
|
|
|
3 |
p. 1073-1093 |
artikel |
49 |
Patients with Axial Spondyloarthritis are Great Consumers of Healthcare Resources, Especially Young and Women: Results from the Spanish Atlas
|
Garrido-Cumbrera, Marco |
|
|
|
3 |
p. 729-739 |
artikel |
50 |
Patterns of Prednisone Use in Patients with Rheumatoid Arthritis Initiating Treatment with Tocilizumab in Routine US Clinical Practice
|
Pappas, Dimitrios A. |
|
2019 |
|
3 |
p. 421-433 |
artikel |
51 |
Photobiomodulation Therapy: A New Light in the Treatment of Systemic Sclerosis Skin Ulcers
|
Spinella, Amelia |
|
|
|
3 |
p. 891-905 |
artikel |
52 |
Prevalence of Renal Impairment in a US Commercially Insured Rheumatoid Arthritis Population: A Retrospective Analysis
|
Giles, Jon T. |
|
|
|
3 |
p. 1383-1391 |
artikel |
53 |
Psoriatic Arthritis in Males and Females: Differences and Similarities
|
Lubrano, Ennio |
|
|
|
3 |
p. 589-599 |
artikel |
54 |
Psoriatic Arthritis: What is Happening at the Joint?
|
Belasco, Jennifer |
|
2019 |
|
3 |
p. 305-315 |
artikel |
55 |
Psychometric Analysis from EMBODY1 and 2 Clinical Trials to Help Select Suitable Fatigue PRO Scales for Future Systemic Lupus Erythematosus Studies
|
Cleanthous, Sophie |
|
|
|
3 |
p. 1287-1301 |
artikel |
56 |
Real-Life Tolerability and Effectiveness of Adalimumab Biosimilar in Rheumatoid Arthritis: ASPIRE Registry Data
|
Kapoor, Sanjiv |
|
2019 |
|
3 |
p. 451-459 |
artikel |
57 |
Real-World Analysis of Therapeutic Patterns in Patients Affected by Rheumatoid Arthritis in Italy: A Focus on Baricitinib
|
Perrone, Valentina |
|
|
|
3 |
p. 657-665 |
artikel |
58 |
Real-World Evidence on Etanercept Biosimilar SB4 in Etanercept-Naïve or Switching Patients: A Systematic Review
|
Ebbers, Hans C. |
|
2019 |
|
3 |
p. 317-338 |
artikel |
59 |
Real-World Safety and Effectiveness of Golimumab in Rheumatic Diseases: Post-Marketing Surveillance in Korea
|
Kim, Hyeongyeong |
|
|
|
3 |
p. 1393-1404 |
artikel |
60 |
Relative Impact of Pain and Fatigue on Work Productivity in Patients with Rheumatoid Arthritis from the RA-BEAM Baricitinib Trial
|
Michaud, Kaleb |
|
2019 |
|
3 |
p. 409-419 |
artikel |
61 |
Residual Disease Associated with Suboptimal Treatment Response in Patients with Psoriatic Arthritis: A Systematic Review of Real-World Evidence
|
Coates, Laura C. |
|
|
|
3 |
p. 803-821 |
artikel |
62 |
Responses to Ixekizumab in Male and Female Patients with Psoriatic Arthritis: Results from Two Randomized, Phase 3 Clinical Trials
|
Eder, Lihi |
|
|
|
3 |
p. 919-933 |
artikel |
63 |
Response to Treatment with Intravenous Golimumab or Infliximab in Rheumatoid Arthritis Patients: PROMIS Results from the Real-World Observational Phase 4 AWARE Study
|
Bingham, Clifton O. |
|
|
|
3 |
p. 659-678 |
artikel |
64 |
Rheumatoid Arthritis: The Impact of Mental Health on Disease: A Narrative Review
|
Lwin, May N. |
|
|
|
3 |
p. 457-471 |
artikel |
65 |
Rheumatology Care in the Face of COVID-19
|
Lubrano, Ennio |
|
|
|
3 |
p. 425-428 |
artikel |
66 |
Safety and Efficacy of Tofacitinib in Patients with Active Psoriatic Arthritis: Interim Analysis of OPAL Balance, an Open-Label, Long-Term Extension Study
|
Nash, Peter |
|
|
|
3 |
p. 553-580 |
artikel |
67 |
Secukinumab Efficacy on Psoriatic Arthritis GRAPPA-OMERACT Core Domains in Patients with or Without Prior Tumor Necrosis Factor Inhibitor Use: Pooled Analysis of Four Phase 3 Studies
|
Orbai, Ana-Maria |
|
|
|
3 |
p. 1223-1240 |
artikel |
68 |
Self-Reported Weather Sensitivity is Associated with Clinical Symptoms and Structural Abnormalities in Patients with Knee Osteoarthritis: A Cross-Sectional Study
|
Xue, Yan |
|
|
|
3 |
p. 1405-1417 |
artikel |
69 |
Sjögren’s Syndrome and Viral Infections
|
Liu, Zhiyong |
|
|
|
3 |
p. 1051-1059 |
artikel |
70 |
Sustained Remission and Outcomes with Abatacept plus Methotrexate Following Stepwise Dose De-escalation in Patients with Early Rheumatoid Arthritis
|
Emery, Paul |
|
|
|
3 |
p. 707-727 |
artikel |
71 |
Systemic Lupus Erythematosus (SLE) Therapy: The Old and the New
|
Basta, Fabio |
|
|
|
3 |
p. 433-446 |
artikel |
72 |
The “Climb” Towards Minimal Disease Activity in Psoriatic Arthritis
|
Lubrano, Ennio |
|
|
|
3 |
p. 1443-1450 |
artikel |
73 |
The Clinical Characteristics of Leukopenia in Patients with Systemic Lupus Erythematosus of Han Ethnicity in China: A Cross-Sectional Study
|
Lu, Wentian |
|
|
|
3 |
p. 1177-1188 |
artikel |
74 |
The Clinical Characteristics of Psoriatic Arthritis: A Cross-Sectional Study Based on the Psoriatic Arthritis Cohort of West China Hospital
|
Wang, Yiyi |
|
|
|
3 |
p. 775-784 |
artikel |
75 |
Therapeutic Effects of Ba-Duan-Jin versus Pregabalin for Fibromyalgia Treatment: Protocol for a Randomized Controlled Trial
|
Yang, Yang |
|
|
|
3 |
p. 1451-1462 |
artikel |
76 |
The Value of Screening for Celiac Disease in Systemic Lupus Erythematosus: A Single Experience of a Tertiary Medical Center
|
AlEnzi, Fahidah |
|
|
|
3 |
p. 649-656 |
artikel |
77 |
TNF-α Blockers Showed Prophylactic Effects in Preventing COVID-19 in Patients with Rheumatoid Arthritis and Seronegative Spondyloarthropathies: A Case–Control Study
|
Salesi, Mansour |
|
|
|
3 |
p. 1355-1370 |
artikel |
78 |
Towards a Better Implementation of Treat-to-Target Strategy in Rheumatoid Arthritis: A Comparison of Two Real-World Cohorts
|
Huang, Hong |
|
|
|
3 |
p. 907-917 |
artikel |
79 |
Translating Improvements with Ixekizumab in Clinical Trial Outcomes into Clinical Practice: ASAS40, Pain, Fatigue, and Sleep in Ankylosing Spondylitis
|
Mease, Philip |
|
2019 |
|
3 |
p. 435-450 |
artikel |
80 |
Trends in Hospitalization for Tuberculosis and Other Opportunistic Infections in Australian Patients with Inflammatory Joint Diseases
|
Nossent, Johannes C. |
|
|
|
3 |
p. 563-573 |
artikel |
81 |
Understanding the Role of Interleukin-6 (IL-6) in the Joint and Beyond: A Comprehensive Review of IL-6 Inhibition for the Management of Rheumatoid Arthritis
|
Favalli, Ennio G. |
|
|
|
3 |
p. 473-516 |
artikel |
82 |
Unmet Needs in the Osteoarthritis Chronic Moderate to Severe Pain Management in Spain: A Real Word Data Study
|
Castro-Domínguez, Francisco |
|
|
|
3 |
p. 1113-1127 |
artikel |
83 |
Usability Study of PF-06410293, an Adalimumab Biosimilar, by Prefilled Pen: Open-Label, Single-Arm, Sub-Study of a Phase 3 Trial in Patients with Rheumatoid Arthritis
|
Fleischmann, Roy M. |
|
|
|
3 |
p. 839-850 |
artikel |
84 |
Virtual Rheumatology During COVID-19: A Personal Perspective
|
Dacre, Jane |
|
|
|
3 |
p. 429-431 |
artikel |